With New FDA Guidance on Real-World Data, What’s the Next Step for Clinical Trials?
In September 2021, the FDA published new draft guidance as part of its ongoing efforts to explore the use of real-world data (RWD) and real-world evidence (RWE) within its regulatory decision-making process.
